SCHEMBL25910299

SCHEMBL25910299

CCCOc1ccc2c(c1)CCS2(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.52
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42
CA9 Q16790 5/20 0.42
CA7 P43166 4/20 0.42
CA14 Q9ULX7 3/20 0.42
CA12 O43570 2/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SLC2A1 P11166 1/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25903923 0.84 GPR119 (0.49) GPR119CA1CA2CA9MAPK1
SCHEMBL19865381 0.79 RYR2 (0.56) GPR119CA1CA2CA9CA5A
SCHEMBL25904287 0.77 MAPK1 (0.44) CA1CA2CA9CA7CA14
SCHEMBL26022348 0.76 GPR119 (0.43) GPR119MAPK1SMN1; SMN2MAPTKDM4E
SCHEMBL26029593 0.74 HRH3 (0.42) CA1CA2CA9CA7CA14
SCHEMBL10071533 0.73 HRH3 (0.51) CA1CA2CA9CA7CA12
SCHEMBL25904264 0.72 AOC3 (0.57) GPR119CA1CA2CA9CA7
SCHEMBL25903936 0.71 HRH3 (0.44) GPR119MAPTALDH1A1HPGDKMT2A
SCHEMBL23222346 0.70 SMN1; SMN2 (0.56) SMN1; SMN2MAPTKDM4ETSHRALDH1A1
SCHEMBL11444799 0.70 TSHR (0.56) MAPK1SMN1; SMN2MAPTKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed